![Stephen M. Notestine](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Stephen M.
Notestine is the founder of Quadrant Properties LLC.
He is currently working as the Director at Sequoia Sciences, Inc. since 1999 and as the Independent Director at Sequoia Vaccines, Inc. since 2021.
He is also a Director at the Roman Catholic Foundation of Eastern Missouri.
Cargos activos de Stephen M. Notestine
Empresas | Cargo | Inicio |
---|---|---|
Sequoia Sciences, Inc.
![]() Sequoia Sciences, Inc. Pharmaceuticals: OtherHealth Technology Sequoia Sciences, Inc. engages in the development of new medicines for the treatment of bacterial infections and cancers. The firm's development programs consist of small molecules targeting bacterial infections and cancers, and vaccines for the treatment and prevention of recurrent urinary tract infections. The company was founded by Gary R. Eldridge, Jr. in 1999 and is headquartered in St. Louis, MO. | Director/Miembro de la Junta | 01/01/1999 |
Quadrant Properties LLC | Fundador | 29/09/2009 |
Sequoia Vaccines, Inc.
![]() Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | Director/Miembro de la Junta | 01/01/2021 |
Roman Catholic Foundation of Eastern Missouri | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Sequoia Sciences, Inc.
![]() Sequoia Sciences, Inc. Pharmaceuticals: OtherHealth Technology Sequoia Sciences, Inc. engages in the development of new medicines for the treatment of bacterial infections and cancers. The firm's development programs consist of small molecules targeting bacterial infections and cancers, and vaccines for the treatment and prevention of recurrent urinary tract infections. The company was founded by Gary R. Eldridge, Jr. in 1999 and is headquartered in St. Louis, MO. | Health Technology |
Quadrant Properties LLC | |
Sequoia Vaccines, Inc.
![]() Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | Health Technology |
Roman Catholic Foundation of Eastern Missouri |
- Bolsa de valores
- Insiders
- Stephen M. Notestine